Coronavirus: World Health Organization discontinues use of hydroxychloroquine in COVID-19 trials

The World Health Organization (WHO) announced on Saturday that it will stop using hydroxychloroquine and the HIV drug combination lopinavir/ritonavir in hospitalized COVID-19 patients. According to the agency, the treatments did not reduce death rates. This decision, however, does not apply to ongoing studies involving non-hospitalized patients or preventive use of the drugs.